"## AMRrules specification v0.6, file updated 2025-09-03"																							
ruleID	txid	organism	gene	nodeID	protein accession	HMM accession	nucleotide accession	ARO accession	mutation	variation type	gene context	drug	drug class	phenotype	clinical category	breakpoint	breakpoint standard	breakpoint condition	PMID	evidence code	evidence grade	evidence limitations	rule curation note
YER0001	633	s__Yersinia pseudotuberculosis	aph(6)-Id	aph(6)-Id	WP_000480972.1	-	-	ARO:3002660	-	Gene presence detected	acquired	streptomycin	-	nonwildtype	R	Disk zone <11 mm	CLSI M100Ed35E (2025)	-	28830739	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. pseudotuberculosis showing that gene acquisition is associated with Streptomycin resistance.
YER0002	633	s__Yersinia pseudotuberculosis	ant(3'')-Ia	ant(3'')-Ia	WP_071846263.1	-	-	ARO:3000232	-	Gene presence detected	acquired	streptomycin	-	nonwildtype	R	Disk zone <11 mm	CLSI M100Ed35E (2025)	-	28830739	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. pseudotuberculosis showing that gene acquisition is associated with Streptomycin resistance.
YER0003	633	s__Yersinia pseudotuberculosis	aph(3'')-Ib	aph(3'')-Ib	-	NF032895.1	-	ARO:3002639	-	Gene presence detected	acquired	streptomycin	-	nonwildtype	R	Disk zone <11 mm	CLSI M100Ed35E (2025)	-	28830739	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. pseudotuberculosis showing that gene acquisition is associated with Streptomycin resistance.
YER0004	633	s__Yersinia pseudotuberculosis	blaOXA-2	blaOXA-2	WP_001007673.1	-	-	ARO:3001397	-	Gene presence detected	acquired	amoxicillin	-	nonwildtype	R	MIC >8 mg/L	EUCAST v15.0 (2025)	Uncomplicated urinary tract infection	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. pseudotuberculosis showing that gene acquisition is associated with Amoxicillin resistance.
YER0005	633	s__Yersinia pseudotuberculosis	blaTEM-1	blaTEM-1	AAR25033.1	-	-	ARO:3000873	-	Gene presence detected	acquired	amoxicillin	-	nonwildtype	R	MIC >8 mg/L	EUCAST v15.0 (2025)	Uncomplicated urinary tract infection	28830739	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. pseudotuberculosis showing that gene acquisition is associated with Amoxicillin resistance.
YER0006	633	s__Yersinia pseudotuberculosis	blaTEM-1	blaTEM-1	AAR25033.1	-	-	ARO:3000873	-	Gene presence detected	acquired	ticarcillin	-	nonwildtype	R	not applicable	EUCAST Expected resistant phenotypes v1.2 (2023)	-	28830739	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. pseudotuberculosis showing that gene acquisition is associated with Ticarcillin resistance.
YER0007	633	s__Yersinia pseudotuberculosis	dfrA1	dfrA1	WP_000777554.1	-	-	ARO:3002854	-	Gene presence detected	acquired	trimethoprim	-	nonwildtype	R	MIC >4 mg/L	EUCAST v15.0 (2025)	-	28830739	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. pseudotuberculosis showing that gene acquisition is associated with Trimethoprim resistance.
YER0008	633	s__Yersinia pseudotuberculosis	dfrA14	dfrA14	WP_021529707.1	-	-	ARO:3002859	-	Gene presence detected	acquired	trimethoprim	-	nonwildtype	R	MIC >4 mg/L	EUCAST v15.0 (2025)	-	28830739	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. pseudotuberculosis showing that gene acquisition is associated with Trimethoprim resistance.
YER0009	633	s__Yersinia pseudotuberculosis	sul1	sul1	-	NF000294.1	-	ARO:3000410	-	Gene presence detected	acquired	sulfamethoxazole	-	nonwildtype	R	MIC >=256 mg/L	CLSI M100Ed35E (2025)	-	28830739	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. pseudotuberculosis showing that gene acquisition is associated with Sulfamethoxazole resistance.
YER0010	633	s__Yersinia pseudotuberculosis	sul2	sul2	-	NF000295.1	-	ARO:3000412	-	Gene presence detected	acquired	sulfamethoxazole	-	nonwildtype	R	MIC >=256 mg/L	CLSI M100Ed35E (2025)	-	28830739	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. pseudotuberculosis showing that gene acquisition is associated with Sulfamethoxazole resistance.
YER0011	633	s__Yersinia pseudotuberculosis	tetA(A)	-	CAD57192.1	-	-	-	-	Gene presence detected	acquired	tetracycline	-	nonwildtype	R	MIC >=16 mg/L	CLSI M100Ed35E (2025)	-	28830739	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. pseudotuberculosis showing that gene acquisition is associated with Tetracyclin resistance.
YER0012	633	s__Yersinia pseudotuberculosis	tetA(D)	-	AAL75563.1	-	-	-	-	Gene presence detected	acquired	tetracycline	-	nonwildtype	R	MIC >=16 mg/L	CLSI M100Ed35E (2025)	-	28830739	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. pseudotuberculosis showing that gene acquisition is associated with Tetracyclin resistance.
YER0013	633	s__Yersinia pseudotuberculosis	catA2	catA2	WP_011751353.1	-	-	-	-	Gene presence detected	acquired	chloramphenicol	-	nonwildtype	R	MIC >=32 mg/L	CLSI M100Ed35E (2025)	-	28830739	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. pseudotuberculosis showing that gene acquisition is associated with Chloramphenicolresistance.
YER0014	630	s__Yersinia enterocolitica	gyrA	-	WP_013650157.1	-	-	-	p.Gly81Cys	Protein variant detected	acquired	nalidixic acid	-	nonwildtype	R	MIC >=32 mg/L	CLSI M100Ed35E (2025)	-	15117921	ECO:0000042 gain-of-function mutant phenotypic evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that this mutation in gyrA is associated with Nalidixic acid resistance.
YER0015	630	s__Yersinia enterocolitica	gyrA	-	WP_013650157.1	-	-	-	p.Asp82Ser83Gly	Protein variant detected	acquired	nalidixic acid	-	nonwildtype	R	MIC >=32 mg/L	CLSI M100Ed35E (2025)	-	-	ECO:0000042 gain-of-function mutant phenotypic evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that this mutation in gyrA is associated with Nalidixic acid resistance.
YER0016	630	s__Yersinia enterocolitica	gyrA	-	WP_013650157.1	-	-	-	p.Ser83Ile	Protein variant detected	acquired	nalidixic acid	-	nonwildtype	R	MIC >=32 mg/L	CLSI M100Ed35E (2025)	-	15117921	ECO:0000042 gain-of-function mutant phenotypic evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that this mutation in gyrA is associated with Nalidixic acid resistance.
YER0017	630	s__Yersinia enterocolitica	gyrA	-	WP_013650157.1	-	-	-	p.Ser83Arg	Protein variant detected	acquired	nalidixic acid	-	nonwildtype	R	MIC >=32 mg/L	CLSI M100Ed35E (2025)	-	15117921	ECO:0000042 gain-of-function mutant phenotypic evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that this mutation in gyrA is associated with Nalidixic acid resistance.
YER0018	630	s__Yersinia enterocolitica	gyrA	-	WP_013650157.1	-	-	-	p.Ser83Cys	Protein variant detected	acquired	nalidixic acid	-	nonwildtype	R	MIC >=32 mg/L	CLSI M100Ed35E (2025)	-	15117921	ECO:0000042 gain-of-function mutant phenotypic evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that this mutation in gyrA is associated with Nalidixic acid resistance.
YER0019	630	s__Yersinia enterocolitica	gyrA	-	WP_013650157.1	-	-	-	p.Val85Ile	Protein variant detected	acquired	nalidixic acid	-	nonwildtype	R	MIC >=32 mg/L	CLSI M100Ed35E (2025)	-	15117921	ECO:0000042 gain-of-function mutant phenotypic evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that this mutation in gyrA is associated with Nalidixic acid resistance.
YER0020	630	s__Yersinia enterocolitica	gyrA	-	WP_013650157.1	-	-	-	p.Asp87Gly	Protein variant detected	acquired	nalidixic acid	-	nonwildtype	R	MIC >=32 mg/L	CLSI M100Ed35E (2025)	-	15117921	ECO:0000042 gain-of-function mutant phenotypic evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that this mutation in gyrA is associated with Nalidixic acid resistance.
YER0021	630	s__Yersinia enterocolitica	gyrA	-	WP_013650157.1	-	-	-	p.Asp87Asn	Protein variant detected	acquired	nalidixic acid	-	nonwildtype	R	MIC >=32 mg/L	CLSI M100Ed35E (2025)	-	15117921	ECO:0000042 gain-of-function mutant phenotypic evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that this mutation in gyrA is associated with Nalidixic acid resistance.
YER0022	630	s__Yersinia enterocolitica	gyrA	-	WP_013650157.1	-	-	-	p.Asp87Tyr	Protein variant detected	acquired	nalidixic acid	-	nonwildtype	R	MIC >=32 mg/L	CLSI M100Ed35E (2025)	-	12682183	ECO:0000042 gain-of-function mutant phenotypic evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that this mutation in gyrA is associated with Nalidixic acid resistance.
YER0023	630	s__Yersinia enterocolitica	aac(3)-IVa	aac(3)-IVa	WP_001199192.1	-	-	ARO:3002539	-	Gene presence detected	acquired	gentamicin	-	nonwildtype	R	MIC >2 mg/L	EUCAST v15.0 (2025)	Uncomplicated urinary tract infection	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that gene acquisition is associated with gentamicin resistance.
YER0024	630	s__Yersinia enterocolitica	aac(3)-IVa	aac(3)-IVa	WP_001199192.1	-	-	ARO:3002539	-	Gene presence detected	acquired	tobramycin	-	nonwildtype	R	MIC >2 mg/L	EUCAST v15.0 (2025)	Uncomplicated urinary tract infection	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that gene acquisition is associated with Tobramycin resistance.
YER0025	630	s__Yersinia enterocolitica	aph(4)-Ia	aph(4)-Ia	WP_000742814.1	-	-	ARO:3002655	-	Gene presence detected	acquired	gentamicin	-	nonwildtype	R	MIC >2 mg/L	EUCAST v15.0 (2025)	-	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that gene acquisition is associated with Gentamycin resistance.
YER0026	630	s__Yersinia enterocolitica	aph(4)-Ia	aph(4)-Ia	WP_000742814.1	-	-	ARO:3002655	-	Gene presence detected	acquired	tobramycin	-	nonwildtype	R	MIC >2 mg/L	EUCAST v15.0 (2025)	-	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that gene acquisition is associated with Tobramycin resistance.
YER0027	630	s__Yersinia enterocolitica	blaOXA-48	blaOXA-48	WP_015059991.1	-	-	ARO:3001782	-	Gene presence detected	acquired	ertapenem	-	nonwildtype	R	MIC >0.5 mg/L	EUCAST v15.0 (2025)	-	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that gene acquisition is associated with Ertapenem resistance.
YER0028	630	s__Yersinia enterocolitica	dfrA1	dfrA1	WP_000777554.1	-	-	ARO:3002854	-	Gene presence detected	acquired	trimethoprim	-	nonwildtype	R	MIC >4 mg/L	EUCAST v15.0 (2025)	-	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that gene acquisition is associated with Trimethoprim resistance.
YER0029	630	s__Yersinia enterocolitica	dfrA14	dfrA14	WP_021529707.1	-	-	ARO:3002859	-	Gene presence detected	acquired	trimethoprim	-	nonwildtype	R	MIC >4 mg/L	EUCAST v15.0 (2025)	-	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that gene acquisition is associated with Trimethoprim resistance.
YER0030	630	s__Yersinia enterocolitica	dfrB1	dfrB1	WP_000442373.1	-	-	ARO:3002864	-	Gene presence detected	acquired	trimethoprim	-	nonwildtype	R	MIC >4 mg/L	EUCAST v15.0 (2025)	-	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that gene acquisition is associated with Trimethoprim resistance.
YER0031	630	s__Yersinia enterocolitica	sul1	sul1	-	NF000294.1	-	ARO:3000410	-	Gene presence detected	acquired	sulfamethoxazole	-	nonwildtype	R	MIC >=256 mg/L	CLSI M100Ed35E (2025)	-	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that gene acquisition is associated with Sulfamethoxazole resistance.
YER0032	630	s__Yersinia enterocolitica	sul2	sul2	-	NF000295.1	-	ARO:3000412	-	Gene presence detected	acquired	sulfamethoxazole	-	nonwildtype	R	MIC >=256 mg/L	CLSI M100Ed35E (2025)	-	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that gene acquisition is associated with Sulfamethoxazole resistance.
YER0033	630	s__Yersinia enterocolitica	tet(A)	tet(A)	WP_000804064.1	-	-	ARO:3000165	-	Gene presence detected	acquired	tetracycline	-	nonwildtype	R	MIC >=16 mg/L	CLSI M100Ed35E (2025)	-	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that gene acquisition is associated with Tetracyclin resistance.
YER0034	630	s__Yersinia enterocolitica	tet(B)	tet(B)	WP_012881330.1	-	-	ARO:3000166	-	Gene presence detected	acquired	tetracycline	-	nonwildtype	R	MIC >=16 mg/L	CLSI M100Ed35E (2025)	-	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that gene acquisition is associated with Tetracyclin resistance.
YER0035	630	s__Yersinia enterocolitica	tet(C)	tet(C)	WP_001297013.1	-	-	ARO:3000167	-	Gene presence detected	acquired	tetracycline	-	nonwildtype	R	MIC >=16 mg/L	CLSI M100Ed35E (2025)	-	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that gene acquisition is associated with Tetracyclin resistance.
YER0036	630	s__Yersinia enterocolitica	tet(H)	tet(H)	WP_006248867.1	-	-	ARO:3000175	-	Gene presence detected	acquired	tetracycline	-	nonwildtype	R	MIC >=16 mg/L	CLSI M100Ed35E (2025)	-	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that gene acquisition is associated with Tetracyclin resistance.
YER0037	630	s__Yersinia enterocolitica	blaA	blaA_Yent	-	NF033152.0	-	ARO:3004190	-	Gene presence detected	core	amoxicillin	-	wildtype	R	not applicable	EUCAST Expected resistant phenotypes v1.2 (2023)	-	20547799	ECO:0001091 knockout phenotypic evidence	high	-	"Wildtype core gene, all blaA alleles are expected to confer resistance to penicillins, explaining the expected resistant to Amoxicillin"
YER0038	630	s__Yersinia enterocolitica	blaA	blaA_Yent	-	NF033152.0	-	ARO:3004190	-	Gene presence detected	core	amoxicillin-clavulanic acid	-	wildtype	R	not applicable	EUCAST Expected resistant phenotypes v1.2 (2023)	-	20547799	ECO:0001091 knockout phenotypic evidence	high	-	"Wildtype core gene, all blaA alleles are expected to confer resistance to penicillins, explaining the expected resistant to Amoxicillin-clavulanic acid"
YER0039	630	s__Yersinia enterocolitica	blaA	blaA_Yent	-	NF033152.0	-	ARO:3004190	-	Gene presence detected	core	ticarcillin	-	wildtype	R	not applicable	EUCAST Expected resistant phenotypes v1.2 (2023)	-	20547799	ECO:0001091 knockout phenotypic evidence	high	-	"Wildtype core gene, all blaA alleles are expected to confer resistance to penicillins, explaining the expected resistant to Ticarcillin"
YER0040	630	s__Yersinia enterocolitica	blaA	blaA_Yent	-	NF033152.0	-	ARO:3004190	-	Gene presence detected	core	ampicillin-sulbactam	-	wildtype	R	not applicable	EUCAST Expected resistant phenotypes v1.2 (2023)	-	20547799	ECO:0001103 natural variation mutant evidence	high	-	Testing of strains of biotype 2 and 4 resulted in susceptible phenotypes
YER0041	630	s__Yersinia enterocolitica	blaA	blaA_Yent	-	NF033152.0	-	ARO:3004190	-	Gene presence detected	core	cefalexin	-	wildtype	R	not applicable	EUCAST Expected resistant phenotypes v1.2 (2023)	-	20547799	ECO:0001091 knockout phenotypic evidence	high	-	"Wildtype core gene, all blaA alleles are expected to confer resistance to 1st generation cephalosporin, explaining the expected resistant to Cefalexin"
YER0042	630	s__Yersinia enterocolitica	blaA	blaA_Yent	-	NF033152.0	-	ARO:3004190	c.592del_50pb	Inactivating mutation detected	core	ticarcillin	-	wildtype	S	not applicable	-	-	11102414	ECO:0001113 point mutation phenotypic evidence	high	-	"Wildtype core gene, mutation (deletion of 50 bp) in blaA leading to premature stop codon, explaining the susceptibility to ticarcillin (only in bioserotype 2/O:5)"
YER0043	630	s__Yersinia enterocolitica	ampC	-	CBY26916.1	-	-	-	-	Gene presence detected	core	cefoxitin	-	wildtype	R	not applicable	EUCAST Expected resistant phenotypes v1.2 (2023)	-	20547799	ECO:0001091 knockout phenotypic evidence	high	-	"Wildtype core gene, higher induction of ampC in bioserotype 2/O:9 is expected to confer resistance to 2nd generation cephalosporin, explaining the expected resistant to Cefoxitin"
YER0044	630	s__Yersinia enterocolitica	blaTEM-181	blaTEM-181	WP_000027060.1	-	-	ARO:3001044	-	Gene presence detected	acquired	amoxicillin	-	nonwildtype	R	MIC >8 mg/L	EUCAST v15.0 (2025)	-	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Redundant with effect of blaA
YER0046	630	s__Yersinia enterocolitica	floR	floR	-	NF000219.1	-	ARO:3002705	-	Gene presence detected	acquired	chloramphenicol	-	nonwildtype	R	MIC >=32 mg/L	CLSI M100Ed35E (2025)	-	28830739	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that gene acquisition is associated with Chloramphenicolresistance.
YER0048	630	s__Yersinia enterocolitica	qnrB19	qnrB19	WP_012954666.1	-	-	ARO:3002734	-	Gene presence detected	acquired	nalidixic acid	-	nonwildtype	R	MIC >=32 mg/L	CLSI M100Ed35E (2025)	-	-	ECO:0001103 natural variation mutant evidence	moderate	lacks evidence for this genus	Experimental evidence in other Enterobacterales
YER0049	630	s__Yersinia enterocolitica	aph(3')-IIa	aph(3')-IIa	CAA23892.1	-	-	ARO:3002644	-	Gene presence detected	acquired	kanamycin A	-	nonwildtype	R	MIC >=64 mg/L	CLSI M100Ed35E (2025)	-	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	
YER0050	630	s__Yersinia enterocolitica	vat(F)	vat(F)	WP_005164767.1	-	-	ARO:3003744	-	Gene presence detected	core	-	streptogramin antibiotic	wildtype	R	not applicable	ESGEM-AMR	-	38176093	ECO:0001103 natural variation mutant evidence	moderate	lacks evidence for this genus	78.9% Yersinia enterocolotica chromosomes (CARD)
YER0051	630	s__Yersinia enterocolitica	sul3	sul3	-	NF000296.1	-	ARO:3000413	-	Gene presence detected	acquired	sulfamethoxazole	-	nonwildtype	R	MIC >=256 mg/L	CLSI M100Ed35E (2025)	-	28830739	ECO:0001103 natural variation mutant evidence	moderate	lacks evidence for this species	Experimental evidence in Y. pseudotuberculosis showing that gene acquisition is associated with Sulfamethoxazole resistance.
YER0052	630	s__Yersinia enterocolitica	tet(M)	tet(M)	-	NF012155.1	-	ARO:3000186	-	Gene presence detected	acquired	tetracycline	-	nonwildtype	R	MIC >=16 mg/L	CLSI M100Ed35E (2025)	-	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	Experimental evidence in Y. enterocolitica showing that gene acquisition is associated with Tetracyclin resistance.
YER0053	630	s__Yersinia enterocolitica	sat2	sat2_fam	-	NF000358.1	-	ARO:3002895	-	Gene presence detected	acquired	streptothricin	-	nonwildtype	R	not available	-	-	-	ECO:0001103 natural variation mutant evidence	moderate	ENTRY MISSING	
YER0054	630	s__Yersinia enterocolitica	dfrA12	dfrA12	-	NF000053.2	-	ARO:3002858	-	Gene presence detected	acquired	trimethoprim	-	nonwildtype	R	MIC >4 mg/L	EUCAST v15.0 (2025)	-	28830739	ECO:0001103 natural variation mutant evidence	moderate	lacks evidence for this species	Experimental evidence in Y. pseudotuberculosis showing that gene acquisition is associated with Trimethoprim resistance.